(0.16%) 5 477.90 points
(0.04%) 39 128 points
(0.49%) 17 805 points
(0.05%) $80.87
(-5.04%) $2.62
(-0.92%) $2 309.30
(-0.36%) $28.77
(2.85%) $1 014.50
(0.33%) $0.936
(0.72%) $10.68
(0.49%) $0.792
(0.88%) $88.26
-0.60% € 1.650
Live Chart Being Loaded With Signals
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders...
Stats | |
---|---|
Volumen de hoy | 58 363 |
Volumen promedio | 123 350 |
Capitalización de mercado | 134.74M |
EPS | €-0.0944 ( Q1 | 2024-05-09 ) |
Próxima fecha de ganancias | ( €-0.120 ) 2024-08-01 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E |
-4.71 (Sector) 42.63 (Industry) 24.32 |
ATR14 | €0.00600 (0.36%) |
Volumen Correlación
ProQR Therapeutics NV Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ProQR Therapeutics NV Correlación - Moneda/Commodity
ProQR Therapeutics NV Finanzas
Annual | 2023 |
Ingresos: | €6.38M |
Beneficio Bruto: | €6.38M (100.00 %) |
EPS: | €-0.340 |
FY | 2023 |
Ingresos: | €6.38M |
Beneficio Bruto: | €6.38M (100.00 %) |
EPS: | €-0.340 |
FY | 2022 |
Ingresos: | €4.04M |
Beneficio Bruto: | €1.56M (38.68 %) |
EPS: | €-0.910 |
FY | 2021 |
Ingresos: | €1.35M |
Beneficio Bruto: | €0.00 (0.00 %) |
EPS: | €-1.231 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ProQR Therapeutics NV
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico